Scholars@Duke
Kevin Lynch

Kevin Lynch

Clinical Associate in the Department of Surgery, Division of Minimally Invasive Surgery
Surgery, Minimally Invasive Surgery

Selected Publications

Regional control after precision lymph node dissection for clinically evident melanoma metastasis.

Journal Article J Surg Oncol · January 2023 INTRODUCTION: Completion lymph node dissection (CLND) for microscopic lymph node metastases has been replaced by observation; however, CLND is standard for clinically detectable nodal metastases (cLN). CLND has high morbidity, which may be reduced by excis ... Full text Link to item Cite

An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.

Journal Article Ann Surg Oncol · October 2022 BACKGROUND: Merkel cell carcinoma (MCC) is a rare cutaneous malignancy for which factors predictive of disease-specific survival (DSS) are poorly defined. METHODS: Patients from six centers (2005-2020) with clinical stage I-II MCC who underwent sentinel ly ... Full text Link to item Cite

Isolated same-basin lymph node recurrence after precision lymph node excision for clinically evident melanoma metastasis.

Conference Journal of Clinical Oncology · May 20, 2021 9576 Background: While management of the nodal basin for melanoma has largely moved to observation for microscopic sentinel lymph node (SLN) metastasis, complete lymph node dissection (CLND) remains the current standard of care f ... Full text Cite